Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque

Stroke

Volumn 32, Issue 4, 2001, Pages 855-860

  LaBiche, Ronald ^a   Koziol, Deloris ^b   Quinn, Thomas C ^c   Gaydos, Charlotte ^c   Azhar, Salman ^a,d   Ketron, Gary ^d   Sood, Suman ^a   DeGraba, Thomas J ^a,e  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Atherosclerosis; Carotid arteries; Chlamydia; Immunoglobulin; Symptoms

Indexed keywords

DNA; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0035075968     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.32.4.855     Document Type: Article

References (35)

1. Atherosclerosis: An inflammatory disease
2. Roles of infectious agents in atherosclerosis and restenosis: An assessment of the evidence and need for future research
3. Infection and atherosclerosis: Emerging mechanistic paradigms
4. Infectious agents that play a role in atherosclerosis and vasculopathies: What are they? What do we do about them?
5. Induction endothelial cell procoagulant activity by cytomegalovirus infection
6. Introduction of endothelial adhesion molecules by rat cytomegalovirus in allogenic lung transplantation in the rat
7. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression
8. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
9. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease
10. Cellular oxidation of low density lipoprotein by Chlamydia pneumoniae
11. Antigen processing and presentation to T lymphocytes
12. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits
13. Rabbit model for Chlamydia pneumoniae infection
14. Chlamydia pneumoniae accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
15. Chlamydia pneumoniae infection and incident coronary heart disease: The Atherosclerosis Risk in Communities Study
16. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries
17. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical staining
18. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
19. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis
20. Association of chlamydial infection with cerebrovascular disease
21. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery
22. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen
23. WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics
24. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: The final report of the ROXIS Study
25. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study
26. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis
27. ACAS recommendations for carotid endarterectomy: ACAS Executive Committee
28. Detection of Chlamydia pneumoniae by polymerase chain reaction
29. Formalinized Chlamydia trachomatis organisms as antigens in the micro-immunofluorescence test
30. Chlamydia pneumoniae serology: Interlaboratory variation in microimmunofluorescence assay results
31. Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis
32. Chlamydia pneumoniae (TWAR)
33. Chlamydia pneumoniae: Specific cell-mediated and humoral immunity in healthy people
34. Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study
35. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia